Literature DB >> 18794292

CadA negatively regulates Escherichia coli O157:H7 adherence and intestinal colonization.

Roberto C Vazquez-Juarez1, Jeeba A Kuriakose, David A Rasko, Jennifer M Ritchie, Melissa M Kendall, Terry M Slater, Mala Sinha, Bruce A Luxon, Vsevolod L Popov, Matthew K Waldor, Vanessa Sperandio, Alfredo G Torres.   

Abstract

Adherence of pathogenic Escherichia coli strains to intestinal epithelia is essential for infection. For enterohemorrhagic E. coli (EHEC) serotype O157:H7, we have previously demonstrated that multiple factors govern this pathogen's adherence to HeLa cells (A. G. Torres and J. B. Kaper, Infect. Immun. 71:4985-4995, 2003). One of these factors is CadA, a lysine decarboxylase, and this protein has been proposed to negatively regulate virulence in several enteric pathogens. In the case of EHEC strains, CadA modulates expression of the intimin, an outer membrane adhesin involved in pathogenesis. Here, we inactivated cadA in O157:H7 strain 86-24 to investigate the role of this gene in EHEC adhesion to tissue-cultured monolayers, global gene expression patterns, and colonization of the infant rabbit intestine. The cadA mutant did not possess lysine decarboxylation activity and was hyperadherent to tissue-cultured cells. Adherence of the cadA mutant was nearly twofold greater than that of the wild type, and the adherence phenotype was independent of pH, lysine, or cadaverine in the media. Additionally, complementation of the cadA defect reduced adherence back to wild-type levels, and it was found that the mutation affected the expression of the intimin protein. Disruption of the eae gene (intimin-encoding gene) in the cadA mutant significantly reduced its adherence to tissue-cultured cells. However, adherence of the cadA eae double mutant was greater than that of an 86-24 eae mutant, suggesting that the enhanced adherence of the cadA mutant is not entirely attributable to enhanced expression of intimin in this background. Gene array analysis revealed that the cadA mutation significantly altered EHEC gene expression patterns; expression of 1,332 genes was downregulated and that of 132 genes was upregulated in the mutant compared to the wild-type strain. Interestingly, the gene expression variation shows an EHEC-biased gene alteration including intergenic regions. Two putative adhesins, flagella and F9 fimbria, were upregulated in the cadA mutant, suggestive of their association with adherence in the absence of the Cad regulatory mechanism. In the infant rabbit model, the cadA mutant outcompeted the wild-type strain in the ileum but not in the cecum or mid-colon, raising the possibility that CadA negatively regulates EHEC pathogenicity in a tissue-specific fashion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794292      PMCID: PMC2573373          DOI: 10.1128/IAI.00677-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Inability to decarboxylate lysine as a presumptive marker to identify Shiga toxin-producing Escherichia coli strains of serogroup O111.

Authors:  Beatriz E C Guth; Tânia A T Gomes; Tânia M I Vaz; Kinue Irino
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987.

Authors:  P I Tarr; M A Neill; C R Clausen; J W Newland; R J Neill; S L Moseley
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

3.  High efficiency transformation of E. coli by high voltage electroporation.

Authors:  W J Dower; J F Miller; C W Ragsdale
Journal:  Nucleic Acids Res       Date:  1988-07-11       Impact factor: 16.971

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Identification and characterization of lpfABCC'DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7.

Authors:  Alfredo G Torres; Jorge A Giron; Nicole T Perna; Valerie Burland; Fred R Blattner; Fabiola Avelino-Flores; James B Kaper
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Characterization of the second long polar (LP) fimbriae of Escherichia coli O157:H7 and distribution of LP fimbriae in other pathogenic E. coli strains.

Authors:  Alfredo G Torres; Kristen J Kanack; Christopher B Tutt; Vsevolod Popov; James B Kaper
Journal:  FEMS Microbiol Lett       Date:  2004-09-15       Impact factor: 2.742

7.  Multiple elements controlling adherence of enterohemorrhagic Escherichia coli O157:H7 to HeLa cells.

Authors:  Alfredo G Torres; James B Kaper
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Virulence properties and characteristics of Shiga toxin-producing Escherichia coli in São Paulo, Brazil, from 1976 through 1999.

Authors:  T M I Vaz; K Irino; M A M F Kato; A M G Dias; T A T Gomes; M I C Medeiros; M M M Rocha; B E C Guth
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

9.  Characterization of Cah, a calcium-binding and heat-extractable autotransporter protein of enterohaemorrhagic Escherichia coli.

Authors:  Alfredo G Torres; Nicole T Perna; Valerie Burland; Abdul Ruknudin; Fred R Blattner; James B Kaper
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  18 in total

1.  Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24.

Authors:  Melissa M Kendall; Charley C Gruber; David A Rasko; David T Hughes; Vanessa Sperandio
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

2.  The Serotonin Neurotransmitter Modulates Virulence of Enteric Pathogens.

Authors:  Aman Kumar; Regan M Russell; Reed Pifer; Zelia Menezes-Garcia; Santiago Cuesta; Sanjeev Narayanan; John B MacMillan; Vanessa Sperandio
Journal:  Cell Host Microbe       Date:  2020-06-09       Impact factor: 21.023

3.  ATP requirement for acidic resistance in Escherichia coli.

Authors:  Yirong Sun; Toshihiko Fukamachi; Hiromi Saito; Hiroshi Kobayashi
Journal:  J Bacteriol       Date:  2011-04-08       Impact factor: 3.490

4.  EHEC Adhesins.

Authors:  Brian D McWilliams; Alfredo G Torres
Journal:  Microbiol Spectr       Date:  2014

Review 5.  Antivirulence genes: insights into pathogen evolution through gene loss.

Authors:  Kimberly A Bliven; Anthony T Maurelli
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

6.  The Type Three Secretion System 2-Encoded Regulator EtrB Modulates Enterohemorrhagic Escherichia coli Virulence Gene Expression.

Authors:  Deborah H Luzader; Graham G Willsey; Matthew J Wargo; Melissa M Kendall
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

7.  A pathoadaptive deletion in an enteroaggregative Escherichia coli outbreak strain enhances virulence in a Caenorhabditis elegans model.

Authors:  Jennifer Hwang; Lisa M Mattei; Laura G VanArendonk; Philip M Meneely; Iruka N Okeke
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

8.  Integration host factor is required for the induction of acid resistance in Escherichia coli.

Authors:  Hongkai Bi; Changyi Zhang
Journal:  Curr Microbiol       Date:  2014-05-10       Impact factor: 2.188

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro.

Authors:  Elena Deligianni; Sally Pattison; Daniel Berrar; Nigel G Ternan; Richard W Haylock; John E Moore; Stuart J Elborn; James S G Dooley
Journal:  BMC Microbiol       Date:  2010-02-08       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.